
SiriusPoint (SPNT) Earnings
Price: $16.50
Market Cap: $2.68B
Market Cap: $2.68B
Revenue (TTM): $2.60B
Net Income: $199.90M
Net Income: $199.90M
P/E Ratio: 13.75
EPS (TTM): $1.20
EPS (TTM): $1.20
Earnings Dates
SiriusPoint (SPNT) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 28, 2025
- Time of Day: Before Market Open
- Estimated EPS: $N/A
Last Earnings Report
- Date: February 18, 2025
- EPS: $-0.13
- EPS Estimate: $0.4
SiriusPoint's next earnings report is scheduled for April 28, 2025.
In its last earnings report on February 18, 2025, SiriusPoint reported earnings per share (EPS) of $-0.13, compared to an estimated EPS of $0.40. The company reported revenue of $625.70M, compared to an estimated revenue of $-.
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-02-19 | N/A | N/A |
Read Transcript | Q3 | 2024 | 2024-11-01 | N/A | N/A |
Read Transcript | Q2 | 2024 | 2024-08-02 | N/A | N/A |
Read Transcript | Q1 | 2024 | 2024-05-01 | N/A | N/A |
Read Transcript | Q4 | 2023 | 2024-02-21 | N/A | N/A |
Read Transcript | Q3 | 2023 | 2023-11-09 | N/A | N/A |
Read Transcript | Q2 | 2023 | 2023-08-05 | N/A | N/A |
Read Transcript | Q1 | 2023 | 2023-05-06 | N/A | N/A |
Read Transcript | Q4 | 2022 | 2023-02-24 | N/A | N/A |
Read Transcript | Q3 | 2022 | 2022-11-06 | N/A | N/A |
Read Transcript | Q2 | 2022 | 2022-08-06 | N/A | N/A |
Read Transcript | Q1 | 2022 | 2022-05-07 | N/A | N/A |
Read Transcript | Q4 | 2021 | 2022-02-25 | N/A | N/A |
Read Transcript | Q3 | 2021 | 2021-11-06 | N/A | N/A |
Read Transcript | Q2 | 2021 | 2021-08-08 | N/A | N/A |
Read Transcript | Q1 | 2021 | 2021-05-14 | N/A | N/A |
Read Transcript | Q4 | 2020 | 2021-02-24 | N/A | N/A |
Read Transcript | Q3 | 2020 | 2020-11-06 | N/A | N/A |
Read Transcript | Q2 | 2020 | 2020-08-07 | N/A | N/A |
Read Transcript | Q1 | 2020 | 2020-05-08 | N/A | N/A |
Read Transcript | Q4 | 2019 | 2020-02-28 | N/A | N/A |
Read Transcript | Q3 | 2019 | 2019-11-06 | N/A | N/A |
Read Transcript | Q2 | 2019 | 2019-08-09 | N/A | N/A |
Read Transcript | Q1 | 2019 | 2019-05-10 | N/A | N/A |
Read Transcript | Q4 | 2018 | 2019-02-28 | N/A | N/A |
Read Transcript | Q3 | 2018 | 2018-11-07 | N/A | N/A |
Read Transcript | Q2 | 2018 | 2018-08-01 | N/A | N/A |
Read Transcript | Q1 | 2018 | 2018-05-13 | N/A | N/A |
Read Transcript | Q4 | 2017 | 2018-03-01 | N/A | N/A |
Read Transcript | Q3 | 2017 | 2017-11-09 | N/A | N/A |
Read Transcript | Q2 | 2017 | 2017-08-03 | N/A | N/A |
Read Transcript | Q1 | 2017 | 2017-05-05 | N/A | N/A |
Read Transcript | Q4 | 2016 | 2017-02-24 | N/A | N/A |
Read Transcript | Q3 | 2016 | 2016-11-04 | N/A | N/A |
Read Transcript | Q2 | 2016 | 2016-08-05 | N/A | N/A |
Read Transcript | Q1 | 2016 | 2016-05-06 | N/A | N/A |
Earnings History
Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
---|---|---|---|---|
February 18, 2025 | $-0.13 | $0.40 | $625.70M | $- |
October 31, 2024 | $0.03 | $0.05 | $562.20M | $- |
August 01, 2024 | $0.57 | $0.40 | $743.30M | $- |
April 30, 2024 | $0.49 | $0.35 | $685.50M | $- |
February 20, 2024 | $0.50 | $0.28 | $645.80M | $- |
November 08, 2023 | $0.32 | $0.20 | $767.90M | $- |
August 02, 2023 | $0.37 | $0.10 | $750.50M | $- |
May 03, 2023 | $0.78 | $0.30 | $684.80M | $- |
February 23, 2023 | $-0.17 | $0.47 | $612.10M | $- |
November 02, 2022 | $-0.61 | $-0.30 | $51.60M | $- |
August 03, 2022 | $-0.38 | $-0.15 | $56.50M | $- |
May 04, 2022 | $-1.36 | $-0.40 | $380.80M | $- |
February 24, 2022 | $-0.88 | $0.27 | $425.50M | $97.15M |
November 03, 2021 | $-0.34 | $-0.60 | $748.70M | $46.01M |
August 05, 2021 | $0.37 | $0.30 | $549.50M | $101.90M |
May 10, 2021 | $1.05 | $0.60 | $463.50M | $430.19M |
February 23, 2021 | $1.43 | $2.00 | $378.46M | $486.33M |
November 05, 2020 | $0.73 | $0.90 | $257.78M | $- |
August 06, 2020 | $1.33 | $1.20 | $278.82M | $- |
Annual Earnings
Annual Revenue
$2.60B
Fiscal Year 2024Annual Net Income
$199.90M
Fiscal Year 2024Annual EPS
$1.34
Fiscal Year 2024Quarterly Earnings
Revenue
$625.70M
Quarter Ending December 31, 2024Net Income
$-17.30M
Quarter Ending December 31, 2024EPS
$-0.17
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
7.32%
Year Ending December 31, 2024P/E Ratio
13.65
Year Ending December 31, 2024Revenue Per Share
$15.63
Year Ending December 31, 2024Earnings Yield (TTM)
7.27%
Trailing Twelve MonthsP/E Ratio (TTM)
13.75
Trailing Twelve MonthsRevenue Per Share (TTM)
$15.71
Trailing Twelve MonthsFrequently Asked Questions
SiriusPoint's next earnings date is scheduled for April 28, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 18, 2025, SiriusPoint reported earnings per share (EPS) of $-0.13, compared to an estimated EPS of $0.40. The company reported revenue of $625.70M, compared to an estimated revenue of $-.
SiriusPoint's current Price-to-Earnings (P/E) ratio is 13.65. The trailing twelve months (TTM) P/E ratio is 13.75. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, SiriusPoint reported total revenue of $2.60B and net income of $199.90M. This represents a net profit margin of 0.0767724096.
SiriusPoint's earnings yield is 7.32%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
SiriusPoint's return on equity (ROE) is 10.32%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
SiriusPoint's gross profit margin is 100.00%. This indicates that for every dollar of revenue, the company retains $1.00 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for SPNT.